Pfizer alopecia drug's FDA approval brings new competition to Eli Lilly

The latest stories trending on MedCity News.

Editor's Pick

Top Story FDA Approval of Pfizer Alopecia Drug Brings New Competition to Eli Lilly Med Pfizer's Litfulo is the first treatment approved for treating adolescents with severe alopecia areata. The drug's approval also covers adults, were it will compete against Eli Lilly's Olumiant. Sponsored Content Why Effective and Efficient Clinical Trial Operations Are More Complex and More Important than Ever in a Post-Pandemic World Presented by Allucent Anita Nelsen, Senior Vice President of Clinical Trial Operations at Allucent, shares her insights on how to navigate the drug development landscape. Calling All Female Physical & Mental Health Startups Need more funding? Want help advertising and spreading the word about how your company is making a difference in female physical and mental health? Then apply today to pitch at MedCity News INVEST Digital Health. Deadline to Apply is Saturday, July 15, 2023. There is no fee to apply. Selected startups will receive a complimentary registration to attend the conference. Apply Today!

Featured News

Introducing Payer's Place, a Video Interview Series Highlighting Healthcare Payer Executive Perspectives The series, part of a content partnership between HLTH and MedCity News, will share insights from executives from both public and private payer organizations based on developments and trends they've seen in the healthcare industry and what keeps them up at night. Why Working with Incumbents Offers a Path to Success for Healthtech Startups To deliver real value in today's highly fragmented market, healthtech startups stand to significantly benefit by working with incumbents. Rather than focusing solely on disruption, these startups working with established partners concentrate on proving demonstrable ROI, clinical value, dollars saved, better outcomes and improved healthcare economics. Eyenuk's New FDA Clearance Could Boost Adoption for Its Diabetic Retinopathy Screening Tech Eyenuk recently received FDA clearance to use the Topcon NW400 retinal camera with its EyeArt AI system, which automatically detects diabetic retinopathy. The company said this FDA clearance makes its system the only AI system that is FDA-cleared for use with multiple retinal cameras produced by different manufacturers. Survey: Employers Aren't Doing Enough To Support Employees' Mental Health A Northeast Business Group on Health survey, published Monday, found that 26% of employers never identify the needs of employees, nor the "awareness and effectiveness" of their mental health programs. About three in ten respondents don't have messaging campaigns through social media and internal platforms on mental health. Better Data Quality Means a Better Future for Public Health Public health is heavily dependent on collecting and sharing accurate patient data. Standards for data collection and interoperability can move the needle toward better health data, but it is up to healthcare organizations to take ownership of their data quality by following best practices and adopting technologies that can detect and eliminate bad patient data before it is disseminated. Lawsuits Against Medicare Drug Negotiations Are Mounting, But They Probably Won't Be Able to Stop The Plan Lawsuits filed in opposition to the White House's drug pricing negotiation program are beginning to mount, but legal experts agree that the plaintiffs' arguments probably won't hold up during a court battle. However, these lawsuits still could delay when the government's ability to negotiate price goes into effect. Tuned Launches Hearing Solution for Teens Tuned's new teen-focused solution, which launches Tuesday, caters to those aged 13 to 17 and will be offered as an employer-sponsored benefit. The program sends parents headphones and an iPad, which comes with two different hearing assessments. FibroGen's Fibrosis Drug Flunks Again in Phase 3, Triggering Cost-Cutting Moves FibroGen drug pamrevlumab has failed a Phase 3 study testing it in the chronic lung disorder idiopathic pulmonary fibrosis. It's the second trial failure for the drug in the past month and the company's third Phase 3 failure in the past two months. New York Signs Law To Protect State Providers Providing Abortion Drug Telemed Services to Out-of-State Patients New York Governor Kathy Hochul signed new legislation that will protect the state's doctors, medical providers and facilitators who prescribe abortion care telehealth services to patients outside of New York from litigation in states where abortion services are banned or restricted.

Resources

MedCity Pivot Podcast: 2 Perspectives on how AI Can Soothe Burnout, Burden of Prior Authorization Presented by MedCity News In this interview with Punit Singh Soni, CEO of Suki and Niall O'Connor, CTO, Cohere Health, they evaluate two areas where AI can have an outsize impact: clinical documentation and prior authorization. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe